Literature DB >> 1417241

Bilateral elastofibroma dorsi.

H G Machens1, R Mechtersheimer, U Göhring, P N Schlag.   

Abstract

Elastofibroma dorsi was diagnosed in a 76-year-old woman with bilateral subscapular tumor masses and a 3-year history of recurrent, right-sided scapular pain. A bilateral tumor extirpation was performed and the patient left the hospital free of symptoms 10 days later. We suggest that both constant trauma with resulting excessive elastin production and collagen degeneration might play a major role in the pathogenesis of this rare proliferative lesion.

Entities:  

Mesh:

Year:  1992        PMID: 1417241     DOI: 10.1016/0003-4975(92)91029-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Active neovascularization and possible vascular-centric development of gastric and periscapular elastofibromas.

Authors:  Keita Kai; Kenichiro Kusano; Masashi Sakai; Masanobu Tabuchi; Seiji Yunotani; Kohji Miyazaki; Osamu Tokunaga
Journal:  Virchows Arch       Date:  2009-01-09       Impact factor: 4.064

2.  Diagnosis of elastofibroma.

Authors:  Cuneyt Tetikkurt; Seza Tetikkurt; Nihal Bayar
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

3.  [Elastofibroma of dual anterior and thoracic dorsal localization in children].

Authors:  Abdelhalim Mahmoudi; Mouhcine Bendahou; Lamiae Chater; Afaf Amarti; Youssef Bouabdallah; My Abderrahmane Afifi
Journal:  Pan Afr Med J       Date:  2015-04-08

4.  [Tumor subscapularis: bilateral dorsal elastofibroma - about a case].

Authors:  Meriem Dlimi; Samira Boukind; Oumkeltoum Elatiqi; Driss Elamrani; Yassine Benchamkha; Saloua Ettalbi
Journal:  Pan Afr Med J       Date:  2015-05-21

5.  Elastofibroma dorsi--differential diagnosis in chest wall tumours.

Authors:  Adrien Daigeler; Peter Maria Vogt; Kay Busch; Werner Pennekamp; Dirk Weyhe; Marcus Lehnhardt; Lars Steinstraesser; Hans-Ulrich Steinau; Cornelius Kuhnen
Journal:  World J Surg Oncol       Date:  2007-02-05       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.